Therapeutic methods involving gastrointestinal implants for administering metabolic agents
AssigneeGI Dynamics, Inc.
InventorScott Schorer
Life of this patent
Estimating the term…
Abstract
The present invention provides combination therapies for treating a metabolic disorder, such as type 2 diabetes, obesity, and related comorbidities (e.g., NASH or NAFLD)) in an individual undergoing treatment with a gastrointestinal implant. The combination therapies described herein include methods for treating an individual with a gastrointestinal implant with a metabolic agent, a bariatric procedure, and/or a microbiota modulator.
Claims20
A method of treating a metabolic disorder in an individual undergoing treatment with a gastrointestinal implant configured to bypass at least part of a small intestine the method comprising administering one or more metabolic agents to the individual in an effective amount and for a duration to treat the metabolic disorder, wherein the gastrointestinal implant comprises a wave anchor and a sleeve with a length from about 1 ft to about 5 ft.
A method of treating a metabolic disorder in an individual undergoing treatment with a gastrointestinal implant configured to bypass at least part of a small intestine, the method comprising one or more bariatric procedures to treat the metabolic disorder.
A method of treating a metabolic disorder in an individual undergoing treatment with a gastrointestinal implant configured to bypass at least part of a small intestine, the method comprising administering one or more microbiota modulators to an individual in an effective amount and for a duration to treat the metabolic disorder, wherein the gastrointestinal implant comprises a sleeve with a length from about 1 ft to about 5 ft.
Dependencies are inferred from the claim text.